Physician profile
Thomas J Wolfe
NPI 1568548642
$2,260.60
in general payments reported to CMS, 2019-2025
8 companies · $16.83 in 2025
The $16.83 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $22.32 · 2021: $147 · 2022: $269 · 2024: $258 · 2025: $16.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,196.80 | 2019-2021 | |
| Microvention, INC. | $579.68 | 2019-2024 | Stent, Web Aneurysm Embolization System, Lvis |
| Imperative Care, INC | $195.44 | 2022 | |
| Penumbra, INC. | $175.44 | 2019 | |
| Scientia Vascular | $73.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.10 | 2024 | |
| Depuy Synthes Sales INC. | $16.83 | 2025 | Embotrap |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.